Logo image of INL.DE

INTEL CORP (INL.DE) Stock Fundamental Analysis

FRA:INL - Deutsche Boerse Ag - US4581401001 - Common Stock - Currency: EUR

17.642  -0.71 (-3.86%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to INL. INL was compared to 51 industry peers in the Semiconductors & Semiconductor Equipment industry. INL may be in some trouble as it scores bad on both profitability and health. INL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year INL was profitable.
INL had a positive operating cash flow in the past year.
INL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years INL had a positive operating cash flow.
INL.DE Yearly Net Income VS EBIT VS OCF VS FCFINL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B

1.2 Ratios

INL has a worse Return On Assets (-9.99%) than 86.79% of its industry peers.
Looking at the Return On Equity, with a value of -19.24%, INL is doing worse than 86.79% of the companies in the same industry.
Industry RankSector Rank
ROA -9.99%
ROE -19.24%
ROIC N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
INL.DE Yearly ROA, ROE, ROICINL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

INL's Gross Margin of 31.67% is on the low side compared to the rest of the industry. INL is outperformed by 84.91% of its industry peers.
INL's Gross Margin has declined in the last couple of years.
INL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
INL.DE Yearly Profit, Operating, Gross MarginsINL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

INL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INL has more shares outstanding
The number of shares outstanding for INL has been increased compared to 5 years ago.
INL has a better debt/assets ratio than last year.
INL.DE Yearly Shares OutstandingINL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
INL.DE Yearly Total Debt VS Total AssetsINL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.18, we must say that INL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of INL (1.18) is worse than 84.91% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that INL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, INL is doing worse than 69.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.18
ROIC/WACCN/A
WACC9.43%
INL.DE Yearly LT Debt VS Equity VS FCFINL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

INL has a Current Ratio of 1.31. This is a normal value and indicates that INL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.31, INL is doing worse than 83.02% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that INL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.93, INL is doing worse than 79.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.93
INL.DE Yearly Current Assets VS Current LiabilitesINL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

The earnings per share for INL have decreased strongly by -64.29% in the last year.
The earnings per share for INL have been decreasing by -36.62% on average. This is quite bad
INL shows a decrease in Revenue. In the last year, the revenue decreased by -3.97%.
The Revenue has been decreasing by -5.90% on average over the past years.
EPS 1Y (TTM)-64.29%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%-27.78%
Revenue 1Y (TTM)-3.97%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%-0.45%

3.2 Future

The Earnings Per Share is expected to grow by 47.57% on average over the next years. This is a very strong growth
INL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.95% yearly.
EPS Next Y-37.41%
EPS Next 2Y27.23%
EPS Next 3Y39.24%
EPS Next 5Y47.57%
Revenue Next Year-4.05%
Revenue Next 2Y0.56%
Revenue Next 3Y2.32%
Revenue Next 5Y1.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INL.DE Yearly Revenue VS EstimatesINL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
INL.DE Yearly EPS VS EstimatesINL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 44.10 indicates a quite expensive valuation of INL.
Compared to the rest of the industry, the Price/Earnings ratio of INL indicates a slightly more expensive valuation: INL is more expensive than 75.47% of the companies listed in the same industry.
INL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.91.
The Price/Forward Earnings ratio is 24.63, which indicates a rather expensive current valuation of INL.
INL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. INL is more expensive than 67.92% of the companies in the same industry.
INL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.77.
Industry RankSector Rank
PE 44.11
Fwd PE 24.63
INL.DE Price Earnings VS Forward Price EarningsINL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as INL.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.11
INL.DE Per share dataINL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

INL's earnings are expected to grow with 39.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.23%
EPS Next 3Y39.24%

0

5. Dividend

5.1 Amount

INL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTEL CORP

FRA:INL (5/23/2025, 7:00:00 PM)

17.642

-0.71 (-3.86%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners66.64%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap76.95B
Analysts56.86
Price Target19.5 (10.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.33
Dividend Growth(5Y)-21.66%
DP-5.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)921.35%
Min EPS beat(2)2.81%
Max EPS beat(2)1839.89%
EPS beat(4)3
Avg EPS beat(4)668%
Min EPS beat(4)-80.55%
Max EPS beat(4)1839.89%
EPS beat(8)7
Avg EPS beat(8)409.81%
EPS beat(12)9
Avg EPS beat(12)276.66%
EPS beat(16)13
Avg EPS beat(16)213.34%
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.96%
Max Revenue beat(2)1.23%
Revenue beat(4)3
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-2.8%
Max Revenue beat(4)1.23%
Revenue beat(8)5
Avg Revenue beat(8)0.48%
Revenue beat(12)6
Avg Revenue beat(12)-1.21%
Revenue beat(16)9
Avg Revenue beat(16)0.3%
PT rev (1m)-7.83%
PT rev (3m)-19.13%
EPS NQ rev (1m)-81.42%
EPS NQ rev (3m)-82.07%
EPS NY rev (1m)-36.38%
EPS NY rev (3m)-38.15%
Revenue NQ rev (1m)-7.4%
Revenue NQ rev (3m)-7.36%
Revenue NY rev (1m)-5%
Revenue NY rev (3m)-5.58%
Valuation
Industry RankSector Rank
PE 44.11
Fwd PE 24.63
P/S 1.64
P/FCF N/A
P/OCF 8.42
P/B 0.87
P/tB 1.22
EV/EBITDA 14.11
EPS(TTM)0.4
EY2.27%
EPS(NY)0.72
Fwd EY4.06%
FCF(TTM)-2.6
FCFYN/A
OCF(TTM)2.09
OCFY11.87%
SpS10.76
BVpS20.24
TBVpS14.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.99%
ROE -19.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.67%
FCFM N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 6.09
Cap/Depr 201.33%
Cap/Sales 43.66%
Interest Coverage N/A
Cash Conversion 140.08%
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.93
Altman-Z 1.18
F-Score3
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)223.59%
Cap/Depr(5y)192.25%
Cap/Sales(3y)44.1%
Cap/Sales(5y)35.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.29%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%-27.78%
EPS Next Y-37.41%
EPS Next 2Y27.23%
EPS Next 3Y39.24%
EPS Next 5Y47.57%
Revenue 1Y (TTM)-3.97%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%-0.45%
Revenue Next Year-4.05%
Revenue Next 2Y0.56%
Revenue Next 3Y2.32%
Revenue Next 5Y1.95%
EBIT growth 1Y-678.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1357.63%
EBIT Next 3Y184.44%
EBIT Next 5Y96.64%
FCF growth 1Y35.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.09%
OCF growth 3Y-34.47%
OCF growth 5Y-24.21%